FAPI-PET/CT: Biodistribution and Preliminary Dosimetry Estimate of Two DOTA-containing FAP-targeting Agents in Patients With Various Cancers

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.118.215913
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Various Forms of 18f-FDG PET and PET/CT Findings in Patients With Polymyalgia Rheumatica

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2015English

FAPI-PET/CT: A New Direction for Diagnostic Imaging in Nuclear Medicine

Radiation Diagnostics, Radiation Therapy
2019English

FAPI-PET/CT: A New Direction for Diagnostic Imaging in Nuclear Medicine

Radiation Diagnostics, Radiation Therapy
2019English

First-In-Human HER2-targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients With Breast Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

FAPI-PET/CT: Mean Intensity of Tracer-Uptake (SUV) in 28 Different Kinds of Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Biodistribution and Radiation Dosimetry of 99mTc-Hmpao-Labeled Monocytes in Patients With Rheumatoid Arthritis

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2008English

Improving PET Quantification of Small Animal [68Ga]DOTA-Labeled PET/CT Studies by Using a CT-Based Positron Range Correction

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Radiation Dosimetry and Biodistribution in Monkey and Man of 11c-Pbr28: A PET Radioligand to Image Inflammation

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2007English

Cardiac PET-CT for Monitoring Medical and Interventional Therapy in Patients With CAD: PET Alone Versus Hybrid PET-CT?

Current Cardiology Reports
Cardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy